GMO Ultra-Short Income ETF
GMOC
3 hedge funds and large institutions have $6M invested in GMO Ultra-Short Income ETF in 2025 Q4 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
60.02% more ownership
Funds ownership: 0% → 60.02% (+60%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Grantham, Mayo, Van Otterloo & Co (GMO)
Boston,
Massachusetts
|
+$5.19M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$564K |
| 3 |
Jane Street
New York
|
+$255K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Grantham, Mayo, Van Otterloo & Co (GMO)
Boston,
Massachusetts
| $5.18M | +$5.19M | +103,700 | New |
|
|
2
Citadel Advisors
Miami,
Florida
| $563K | +$564K | +11,259 | New |
|
|
3
Jane Street
New York
| $254K | +$255K | +5,088 | New |
|
GMOC Hedge Fund Activity: Q4 2025 in Review
3 of the 8,229 institutional investors tracked by Wall St. Rank reported a position in GMO Ultra-Short Income ETF (GMOC) for Q4 2025, worth a combined $6M.
Buyers outnumbered sellers: 3 funds opened new GMOC positions and 0 closed out — a net gain of 3 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Grantham, Mayo, Van Otterloo & Co (GMO), opening a new position worth an estimated $5.19M.
- 3 institutional investors held GMO Ultra-Short Income ETF (GMOC) as of Q4 2025, up from 0 in Q3 2025.
- Funds reported $6M of GMO Ultra-Short Income ETF stock for Q4 2025.
- 3 funds opened new GMO Ultra-Short Income ETF positions in Q4 2025 and 0 closed out, a net change of +3 holders.
- The largest GMO Ultra-Short Income ETF buyer in Q4 2025 was Grantham, Mayo, Van Otterloo & Co (GMO), an estimated $5.19M added.
Based on aggregated 13F filings for Q4 2025.